Overexpression of nuclear factor erythroid 2 (NFE2), a key transcription factor involved in platelet production, or recurrent somatic mutations resulting in a hyperactive, truncated form of NFE2 have been directly linked to the MPN phenotype. Here, NFE2 is linked to myeloproliferative disorder.